Delivery Order SPE2DR25D1202-SPE2DR26F72CH
Award Date 11/12/25
Potential Completion Date 11/13/25
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) with a ceiling value of $1,372.29. This order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price delivery under a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.10 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets in unit dose packages of 100 units. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of August 18, 2025. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,006.46 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) on October 31, 2025, with completion expected by November 3, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procurement procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $11,629.29 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 8, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at...
- The Defense Logistics Agency awarded a $18,664.07 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count units) with a completion date of September 11, 2025. This competitive award, issued as a firm fixed-price delivery order with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,119.21 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of July 22, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order valued at $8,255.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal medical procurement requirements. The award was executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,018.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of November 17, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award involves no set-aside designation, indicating the contract was competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,791.28 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count packages) with a completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,328.04 under firm fixed-price terms, with an ultimate completion date of July 31, 2025. The pharmaceutical products will be delivered to the contracting location in Conshohocken, Pennsylvania, where...